Showing results (101-110 of 132) with videos related to
Sort By:
Pageof 14
Cancer Cell|May 15, 2014
Cross-species regulatory network analysis identifies a synergistic interaction between FOXM1 and CENPF that drives prostate cancer malignancyAlvaro Aytes, Antonina Mitrofanova, Celine Lefebvre, et al.Cancer Research|July 28, 2012
B-Raf activation cooperates with PTEN loss to drive c-Myc expression in advanced prostate cancerJingqiang Wang, Takashi Kobayashi, Nicolas Floc'h, et al.Proceedings of the National Academy of Sciences of the United States of America|August 7, 2013
ETV4 promotes metastasis in response to activation of PI3-kinase and Ras signaling in a mouse model of advanced prostate cancerAlvaro Aytes, Antonina Mitrofanova, Carolyn Waugh Kinkade, et al.Development (Cambridge, England)|January 12, 2007
Fibroblast growth factor receptor 2 tyrosine kinase is required for prostatic morphogenesis and the acquisition of strict androgen dependency for adult tissue homeostasisYongshun Lin, Guoqin Liu, Yongyou Zhang, et al.Science Translational Medicine|September 13, 2013
A molecular signature predictive of indolent prostate cancerShazia Irshad, Mukesh Bansal, Mireia Castillo-Martin, et al.Proceedings of the National Academy of Sciences of the United States of America|November 21, 2020
Functional redundancy of type I and type II receptors in the regulation of skeletal muscle growth by myostatin and activin ASe-Jin Lee, Adam Lehar, Yewei Liu, et al.Proceedings of the National Academy of Sciences of the United States of America|November 7, 2012
Cripto regulates skeletal muscle regeneration and modulates satellite cell determination by antagonizing myostatinOmbretta Guardiola, Peggy Lafuste, Silvia Brunelli, et al.Cancer Research|April 3, 2008
Activator protein-1 transcription factors are associated with progression and recurrence of prostate cancerXuesong Ouyang, Walter J Jessen, Hikmat Al-Ahmadie, et al.Urologic Oncology|June 8, 2025
Combination regimen of intravesical docetaxel, gemcitabine, and cisplatin in patients with BCG-unresponsive bladder cancer: clinical outcomes and genomic correlationsBenjamin I Joffe, John R Christin, Clémentine Le Coz, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 16, 2004
A mouse model of classical late-infantile neuronal ceroid lipofuscinosis based on targeted disruption of the CLN2 gene results in a loss of tripeptidyl-peptidase I activity and progressive neurodegenerationDavid E Sleat, Jennifer A Wiseman, Mukarram El-Banna, et al.Pageof 14